Eran Elinav MD, PhD

Director, Microbiome and Cancer Division, National German Cancer Research Center, Heidelberg, Germany; Professor and Head of the Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel

Leading the Department of Systems Immunology at the Weizmann Institute of Science, Israel, and directs the Microbiome & Cancer division at the National German Cancer Center,Germany. His research centers on unraveling the molecular intricacies of host-microbiome interactions to personalize medicine and nutrition. After earning an MD degree at the Hebrew University of Jerusalem, Dr. Elinav completed internal medicine residency and held a physician-scientist role at the TLV Medical Gastroenterology Institute. He earned a PhD in immunology from the Weizmann Institute, followed by a postdoctoral fellowship at Yale University School of Medicine. Dr. Elinav's impactful work, spanning over 250 publications, explores the effects of host genetics, innate immune function, and environmental factors on the intestinal microbiome, influencing multi-factorial diseases. Recognized for academic excellence, he has received prestigious awards, including the Claire and Emmanuel G. Rosenblatt award; Rappaport prize. Dr. Elinav holds honorary positions globally, including guest professor at the University of Science & Technology of China, senior fellow at the Canadian Institute for Advanced Research, elected member of the European Molecular Biology Organization, and elected fellow of the American Academy of Microbiology. He serves as an international scholar at the Howard Hughes Medical Institute and the Bill & Melinda Gates Foundation.